The Role of Epigenetic Changes in Ovarian Cancer: A Review

被引:6
作者
Qazi, Sahar [1 ]
Sharma, Ashok [2 ]
Raza, Khalid [1 ]
机构
[1] Jamia Millia Islamia, Dept Comp Sci, New Delhi, India
[2] All India Inst Med Sci, Dept Biochem, New Delhi, India
关键词
Ovarian cancer; Epigenetics; Diagnosis; High-grade serous ovarian cancer (HGSOC); Epigenetic modifications; DNA METHYLATION; CPG ISLANDS; HYPERMETHYLATION; HYPOMETHYLATION; REPRESSION; EXPRESSION; PROMOTES;
D O I
10.1007/s40944-021-00505-z
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian cancer (OC) is a third-most lethal cancer among women after breast and cervical cancer. Epigenetics is the study of altered heritable phenotype(s), changes affecting the gene expression and activity without changes in the DNA sequence. DNA methylation, histone modifications and micro-RNA expression play a pivotal role in the development and proliferation of ovarian cancer. These epigenetic changes are stable and are affiliated with specific disease subtypes. Studies discern that these epigenetic changes can be used as potential biomarker strategy or as a therapeutic lead to diagnose and treat OC. This review highlights the role of epigenetic changes leading to ovarian cancer. Also, since these changes are located in the serum, it alleviates their chances of becoming an efficient and accurate diagnostic biomarker.
引用
收藏
页数:10
相关论文
共 100 条
  • [1] Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells
    Abbosh, Phillip H.
    Montgomery, John S.
    Starkey, Jason A.
    Novotny, Milos
    Zuhowski, Eleanor G.
    Egorin, Merrill J.
    Moseman, Annie P.
    Golas, Adam
    Brannon, Kate M.
    Balch, Curtis
    Huang, Tim H. M.
    Nephew, Kenneth P.
    [J]. CANCER RESEARCH, 2006, 66 (11) : 5582 - 5591
  • [2] LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer
    Abdollahi, A
    Pisarcik, D
    Roberts, D
    Weinstein, J
    Cairns, P
    Hamilton, TC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 6041 - 6049
  • [3] Decreased expression of 14-3-3σ is associated with advanced disease in human epithelial ovarian cancer:: Its correlation with aberrant DNA methylation
    Akahira, J
    Sugihashi, Y
    Suzuki, T
    Ito, K
    Niikura, H
    Moriya, T
    Nitta, M
    Okamura, H
    Inoue, S
    Sasano, H
    Okamura, K
    Yaegashi, N
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2687 - 2693
  • [4] Ali I, 2009, REC ADV BIOL BIOMED, P147
  • [5] Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]
  • [6] Epigenetic Changes in Ovarian Cancer
    Balch, Curt
    Fang, Fang
    Matei, Daniela E.
    Huang, Tim H. -M.
    Nephew, Kenneth P.
    [J]. ENDOCRINOLOGY, 2009, 150 (09) : 4003 - 4011
  • [7] Aberrant methylation of PCDH17 gene in high-grade serous ovarian carcinoma
    Baranova, Ivana
    Kovarikova, Helena
    Laco, Jan
    Dvorak, Ondrej
    Sedlakova, Iva
    Palicka, Vladimir
    Chmelarova, Marcela
    [J]. CANCER BIOMARKERS, 2018, 23 (01) : 125 - 133
  • [8] Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion
    Barbolina, Maria V.
    Adley, Brian P.
    Kelly, David L.
    Shepard, Jaclyn
    Fought, Angela J.
    Scholtens, Denise
    Penzes, Peter
    Shea, Lonnie D.
    Stack, M. Sharon
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 816 - 825
  • [9] CpGassoc: an R function for analysis of DNA methylation microarray data
    Barfield, Richard T.
    Kilaru, Varun
    Smith, Alicia K.
    Conneely, Karen N.
    [J]. BIOINFORMATICS, 2012, 28 (09) : 1280 - 1281
  • [10] Expression of the POTE gene family in human ovarian cancer
    Barger, Carter J.
    Zhang, Wa
    Sharma, Ashok
    Chee, Linda
    James, Smitha R.
    Kufel, Christina N.
    Miller, Austin
    Meza, Jane
    Drapkin, Ronny
    Odunsi, Kunle
    Klinkebiel, David
    Karpf, Adam R.
    [J]. SCIENTIFIC REPORTS, 2018, 8